Delivery Order SPE2DB22D1002-SPE2DB25FLGK2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 200 mg capsules (28-count units) on September 15, 2025, with an ultimate completion date of October 6, 2025. The contract is unclassified with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a critical vendor in the federal medical procurement supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed-price contract valued at $12,015.80, with completion scheduled by September 9, 2025. This is a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packaging). This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 200 mg capsules (28-count packages) with a ceiling value of $6,007.90. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The order is scheduled for completion by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $12,015.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by April 29, 2025, with performance at the...
- The Defense Logistics Agency awarded a $12,015.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on June 20, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The delivery order...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp for Tasigna 200 mg capsules (28-count) on July 23, 2025, with an ultimate completion date of August 13, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGK2Delivery Order
The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28 units) on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive product portfolio encompassing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products to support military healthcare programs worldwide. The contract vehicle facilitates deliveries to customers including the Defense Health Agency and U.S. Coast Guard, with DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards and contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/15/25 |